Back to search results

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

HPV Positive Oropharyngeal Squamous Cell Carcinoma · HNSCC

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Fakultni nemocnice Olomouc, Olomuoc, Olomouc, Czechia

    Contact: Study coordinator (Melichar Bohuslav)

  • Hôpital de la Pitié - Salpétrière in Paris, Paris, Paris, France

    Contact: Study coordinator (Jean-Philippe Spano)
    Spano

  • Hospices Civils De Lyon, Lyon, France

    Contact: Study coordinator (Jonathan Thouvenin)

  • CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM), Montpellier, France

    Contact: Study coordinator (Marie Vinches, MD) · Marie.Vinches@icm.unicancer.fr · 0033 467 61 31 51
    Vinches

  • Institut Gustave Roussy, Paris, Paris, France

    Contact: Study coordinator (Caroline Even)

  • Universität Leipzig Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Leipzig, Germany

    Contact: Study coordinator (Andreas Dietz)

  • Orszagos Onkologiai Intezet, Budapest, Budapest, Hungary

    Contact: Study coordinator (Erika Hitre, MD)

  • University of Bergen, Haukeland University Hospital, Bergen, Norway

    Contact: Study coordinator (Marianne Brydoy, MD)

  • Oslo Universitetssykehus, Oslo, Norway

    Contact: Study coordinator (Åse Bratland, MD, PhD)

  • Uniwersyteckie Cetrum Kliniczne, Gdansk, Poland

    Contact: Study coordinator (Rafal Dziadziusczko, Dr)

  • Narodowy Instytut Onkologii-im Marii Sklodowskiej-Curie Panstwowy Instytut, Gliwice, Poland

    Contact: Study coordinator (Tomasz Rutkowski, Dr)

  • KO-MED Centra Kliniczne Lublin II, Lublin, Lublin, Poland

    Contact: Study coordinator (Ludmilla Grzybowska - Szatkowska)

  • Hospital del Mar, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Marta Guix Arnau)

  • Institut Catala d'Oncologia, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Marc Oliva)

  • Hospital Universitario Virgen de las Nieves, Granada, Granada, Spain

    Contact: Study coordinator (Juaquina Martin Galan)

  • MD Anderson Cancer Center, Madrid, Madrid, Spain

    Contact: Study coordinator (Pilar López Criado)

  • East and North Hertfordshire NHS Trust Mount Vernon Hospital, London, United Kingdom

    Contact: Study coordinator (Saira Khalique, Dr)
Study leads

  • Åse Bratland, MD, PhD

    Principal Investigator

    Oslo University Hospital

View source on ClinicalTrials.gov(opens in a new tab)